Brief: Qualigen Therapeutics Provides Corporate Update, Reports First Quarter 2022 Financial Results
13/05/2022 12:38
May 13 (Reuters) - Qualigen Therapeutics Inc QLGN.O :
* QUALIGEN THERAPEUTICS, INC. PROVIDES CORPORATE UPDATE AND
REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS
* Q1 LOSS PER SHARE $0.12
* Q1 REVENUE $700,000
* Q1 EARNINGS PER SHARE VIEW $-0.17, REVENUE VIEW $860500.00
--
REFINITIV IBES DATA
Source text for Eikon: ID:nGNXcgsStW
Further company coverage: QLGN.O
Recent news on Aixcrypto Holdings
See all newsBrief: Aixcrypto - Enters Common Shares Purchase Agreement With Gold King Arthur Holding - SEC Filing
Chief Executive Officer And Director
Brief: Aixcrypto Holdings - Enters Note Purchase Agreement With CABG Acquisition Corp On May 12, 2026 - SEC Filing
Brief: Aixcrypto Holdings Reports First Quarter 2026 Results
AIxCrypto Q1 net loss widens as expenses rise